Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2015, Article ID 598028, 6 pages
http://dx.doi.org/10.1155/2015/598028
Research Article

Plasma Prolidase Activity and Oxidative Stress in Patients with Parkinson’s Disease

1Department of Biochemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh 221005, India
2Department of Neurosurgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh 221005, India
3Division of Biostatistics, Department of Community Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh 221005, India
4Department of Oral Pathology, Jaipur Dental College, Jaipur, Rajasthan 302020, India

Received 17 September 2014; Revised 15 January 2015; Accepted 26 January 2015

Academic Editor: Mohammad M. Khan

Copyright © 2015 Akhilesh Kumar Verma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Savitt, V. L. Dawson, and T. M. Dawson, “Diagnosis and treatment of Parkinson disease: molecules to medicine,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1744–1754, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. D. J. Moore, A. B. West, V. L. Dawson, and T. M. Dawson, “Molecular pathophysiology of Parkinson's disease,” Annual Review of Neuroscience, vol. 28, pp. 57–87, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. M. F. Beal, “Mitochondria, oxidative damage, and inflammation in Parkinson's disease,” Annals of the New York Academy of Sciences, vol. 991, pp. 120–131, 2003. View at Google Scholar · View at Scopus
  4. E. C. Hirsch, S. Vyas, and S. Hunot, “Neuroinflammation in Parkinson's disease,” Parkinsonism and Related Disorders, vol. 18, supplement 1, pp. S210–S212, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Surażynski, W. Miltyk, J. Palka, and J. M. Phang, “Prolidase-dependent regulation of collagen biosynthesis,” Amino Acids, vol. 35, no. 4, pp. 731–738, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Türkbeyler, T. Demir, Y. Pehlivan et al., “Prolidase could Act as a diagnosis and treatment mediator in lung fibrosis,” Inflammation, vol. 35, no. 5, pp. 1747–1752, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Arikanoglu, E. Akil, S. Varol et al., “Relationship of cognitive performance with prolidase and oxidative stress in Alzheimer disease,” Neurological Sciences, vol. 34, no. 12, pp. 2117–2121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Uzar, Y. Tamam, O. Evliyaoglu et al., “Serum prolidase activity and oxidative status in patients with diabetic neuropathy,” Neurological Sciences, vol. 33, no. 4, pp. 875–880, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Selek, A. Altindag, G. Saracoglu, H. Celik, and N. Aksoy, “Prolidase activity and its diagnostic performance in bipolar disorder,” Journal of Affective Disorders, vol. 129, no. 1-3, pp. 84–86, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. A. B. Erbaǧci, M. Araz, M. Tarakçioǧlu, and E. S. Namiduru, “Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus,” Clinical Biochemistry, vol. 35, no. 4, pp. 263–268, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Kumari, A. K. Verma, S. Rungta, R. Mitra, R. Srivastava, and N. Kumar, “Serum prolidase activity, oxidant and antioxidant status in nonulcer dyspepsia and healthy volunteers,” ISRN Biochemistry, vol. 2013, Article ID 182601, 6 pages, 2013. View at Publisher · View at Google Scholar
  12. D. Mantle, G. Falkous, S. Ishiura, P. J. Blanchard, and E. K. Perry, “Comparison of proline endopeptidase activity in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease,” Clinica Chimica Acta, vol. 249, no. 1-2, pp. 129–139, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Kirbas, S. Kirbas, M. C. Cure, and A. Tufekci, “Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with idiopathic Parkinson's disease,” Journal of Clinical Neuroscience, vol. 21, no. 3, pp. 451–455, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. A. K. Verma, S. Chandra, R. G. Singh, T. B. Singh, S. Srivastava, and R. Srivastava, “Serum prolidase activity and oxidative stress in diabetic nephropathy and end stage renal disease: a correlative study with glucose and creatinine,” Biochemistry Research International, vol. 2014, Article ID 291458, 7 pages, 2014. View at Publisher · View at Google Scholar
  15. O. Erel, “A novel automated method to measure total antioxidant response against potent free radical reactions,” Clinical Biochemistry, vol. 37, no. 2, pp. 112–119, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. O. Erel, “A new automated colorimetric method for measuring total oxidant status,” Clinical Biochemistry, vol. 38, no. 12, pp. 1103–1111, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Mitsubuchi, K. Nakamura, S. Matsumoto, and F. Endo, “Inborn errors of proline metabolism,” Journal of Nutrition, vol. 138, no. 10, pp. 2016S–2020S, 2008. View at Google Scholar · View at Scopus
  18. I. Gomes, W. Xiong, T. Miki, and M. R. Rosner, “A proline- and glutamine-rich protein promotes apoptosis in neuronal cells,” Journal of Neurochemistry, vol. 73, no. 2, pp. 612–622, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Pettmann and C. E. Henderson, “Neuronal cell death,” Neuron, vol. 20, no. 4, pp. 633–647, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Wang, A. B. Meriin, N. Zaarur et al., “Abnormal proteins can form aggresome in yeast: aggresome-targeting signals and components of the machinery,” The FASEB Journal, vol. 23, no. 2, pp. 451–463, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Y. Sherman and A. L. Goldberg, “Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases,” Neuron, vol. 29, no. 1, pp. 15–32, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. K. S. P. McNaught, P. Shashidharan, D. P. Perl, P. Jenner, and C. W. Olanow, “Aggresome-related biogenesis of Lewy bodies,” European Journal of Neuroscience, vol. 16, no. 11, pp. 2136–2148, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. T. B. Shea, Y.-L. Zheng, D. Ortiz, and H. C. Pant, “Cyclin-dependent kinase 5 increases perikaryal neurofilament phosphorylation and inhibits neurofilament axonal transport in response to oxidative stress,” Journal of Neuroscience Research, vol. 76, no. 6, pp. 795–800, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Sobue, Y. Hashizume, T. Yasuda et al., “Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells,” Acta Neuropathologica, vol. 79, no. 4, pp. 402–408, 1990. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Ikeda, Y. Nakamura, T. Kiyozuka et al., “Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression,” Neurodegenerative Diseases, vol. 8, no. 4, pp. 252–258, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. R. L. Miller, M. James-Kracke, G. Y. Sun, and A. Y. Sun, “Oxidative and inflammatory pathways in Parkinson's disease,” Neurochemical Research, vol. 34, no. 1, pp. 55–65, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Betarbet, T. B. Sherer, and J. T. Greenamyre, “Ubiquitin-proteasome system and Parkinson's diseases,” Experimental Neurology, vol. 191, supplement 1, pp. S17–S27, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. P. L. Kok, H. H. Shan, R. de Silva, B. K. H. Tan, and Z. Z. Yi, “Oxidative stress: apoptosis in neuronal injury,” Current Alzheimer Research, vol. 3, no. 4, pp. 327–337, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Serafini and D. del Rio, “Understanding the association between dietary antioxidants, redox status and disease: is the total antioxidant capacity the right tool?” Redox Report, vol. 9, no. 3, pp. 145–152, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Sharma, P. Kaur, B. Kumar, S. Prabhakar, and K. D. Gill, “Plasma lipid peroxidation and antioxidant status of Parkinson's disease patients in the Indian population,” Parkinsonism and Related Disorders, vol. 14, no. 1, pp. 52–57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Hattiangady, R. Kuruba, and A. K. Shetty, “Acute seizures in old age leads to a greater loss of CA1 pyramidal neurons, an increased propensity for developing chronic TLE and a severe cognitive dysfunction,” Aging and Disease, vol. 2, no. 1, pp. 1–17, 2011. View at Google Scholar
  32. H.-C. Cheng, C. M. Ulane, and R. E. Burke, “Clinical progression in Parkinson disease and the neurobiology of axons,” Annals of Neurology, vol. 67, no. 6, pp. 715–725, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. S. K. van den Eeden, C. M. Tanner, A. L. Bernstein et al., “Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity,” The American Journal of Epidemiology, vol. 157, no. 11, pp. 1015–1022, 2003. View at Publisher · View at Google Scholar · View at Scopus